Literature DB >> 6843360

Lipoprotein levels in morbidly obese patients with massive, surgically-induced weight loss.

B Gonen, J D Halverson, G Schonfeld.   

Abstract

Abnormalities in lipoprotein metabolism are among the risk factors for atherosclerotic cardiovascular disease frequently present in patients with morbid obesity. We have examined the effects of dietary restriction induced by gastric bypass surgery on plasma lipoprotein levels in 22 morbidity obese patients. Operation induced weight loss in all patients. Postoperatively (12 +/- 7 mo), triglycerides decreased from 146.4 +/- 67 (mean +/- S.D. before operation) to 104 +/- 44 mg/dl (p less than 0.01), total cholesterol decreased from 187 +/- 52 to 166 +/- 39 mg/dl (p less than 0.025), LDL cholesterol levels decreased from 119 +/- 42 to 104 +/- 36 mg/dl (p less than 0.038), and HDL cholesterol levels increased from 40.1 +/- 10.1 to 45.2 +/- 9.5 mg/dl (p less than 0.012). HDL cholesterol to LDL cholesterol ratio increased from 0.37 +/- 0.13 to 0.48 +/- 0.21 (p less than 0.01). The results of apo A-1, A-2 and B determinations (n = 12) paralleled the changes in lipoprotein levels. Apo A1/Apo A2 ratio increased suggesting an increase in the concentration of HDL2. We conclude that weight loss following gastric bypass surgery is associated with favorable changes in lipoprotein metabolism which may help prevent or delay the development of atherosclerotic cardiovascular disease. The mechanism responsible for the lipoprotein changes remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843360     DOI: 10.1016/0026-0495(83)90012-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity.

Authors:  R E Brolin; L J Bradley; A C Wilson; R P Cody
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

Review 2.  A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.

Authors:  Kirstin A Carswell; Ajay P Belgaumkar; Stephanie A Amiel; Ameet G Patel
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

3.  Laparoscopic gastric banding: a minimally invasive surgical treatment for morbid obesity: prospective study of 500 consecutive patients.

Authors:  Franck Zinzindohoue; Jean-Marc Chevallier; Richard Douard; Nejib Elian; Jean-Marc Ferraz; Jean-Philippe Blanche; Jean-Louis Berta; Jean-Jacques Altman; Denis Safran; Paul-Henri Cugnenc
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

4.  Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass.

Authors:  Derek M Culnan; Robert N Cooney; Bruce Stanley; Christopher J Lynch
Journal:  Obesity (Silver Spring)       Date:  2008-10-23       Impact factor: 5.002

5.  Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study.

Authors:  Elin Rebecka Carlsson; Kristine H Allin; Sten Madsbad; Mogens Fenger
Journal:  Lipids Health Dis       Date:  2019-09-05       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.